deltatrials
Active Not Recruiting PHASE4 INTERVENTIONAL 2-arm NCT03240809

An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Brodalumab in Pediatric Subjects

An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Brodalumab in Pediatric Subjects (6 to < 18 Years Old) With Severe Plaque Psoriasis

Sponsor: Bausch Health Americas, Inc.

Conditions Psoriasis
Interventions Brodalumab
Updated 13 times since 2017 Last updated: Sep 14, 2025 Started: Jan 24, 2020 Primary completion: Dec 31, 2028 Completion: Jun 30, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03240809, this PHASE4 trial focuses on Psoriasis and remains ongoing. Sponsored by Bausch Health Americas, Inc., it has been updated 13 times since 2020, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Sep 2017 – ~Jun 2018 · 9 months · monthly snapshot~Jun 2018 – ~Jun 2019 · 12 months · monthly snapshot~Jun 2019 – ~Dec 2019 · 6 months · monthly snapshot~Dec 2019 – ~Feb 2020 · 2 months · monthly snapshot~Feb 2020 – ~Jan 2021 · 11 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Oct 2021 · 8 months · monthly snapshot~Oct 2021 – ~Sep 2022 · 11 months · monthly snapshot~Sep 2022 – ~Sep 2023 · 12 months · monthly snapshot~Sep 2023 – ~Jul 2024 · 10 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Oct 2025 · 13 months · monthly snapshot~Oct 2025 – present · 11 months · monthly snapshot

Change History

13 versions recorded

  1. Oct 2025 — Present [monthly]

    Active Not Recruiting PHASE4

    Status: Recruiting → Active Not Recruiting

  2. Sep 2024 — Oct 2025 [monthly]

    Recruiting PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE4

  4. Sep 2023 — Jul 2024 [monthly]

    Recruiting PHASE4

  5. Sep 2022 — Sep 2023 [monthly]

    Recruiting PHASE4

▶ Show 8 earlier versions

  1. Oct 2021 — Sep 2022 [monthly]

    Recruiting PHASE4

  2. Feb 2021 — Oct 2021 [monthly]

    Recruiting PHASE4

  3. Jan 2021 — Feb 2021 [monthly]

    Recruiting PHASE4

  4. Feb 2020 — Jan 2021 [monthly]

    Recruiting PHASE4

  5. Dec 2019 — Feb 2020 [monthly]

    Recruiting PHASE4

    Status: Not Yet Recruiting → Recruiting

  6. Jun 2019 — Dec 2019 [monthly]

    Not Yet Recruiting PHASE4

  7. Jun 2018 — Jun 2019 [monthly]

    Not Yet Recruiting PHASE4

  8. Sep 2017 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Bausch Health Americas, Inc.
Data source: Bausch Health Americas, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations